An underground market for unlicensed weight-loss drugs is being driven by social media fitness personalities and vendors on messaging platforms, according to new investigations.
Experimental Treatment Acquiring Popularity Via Social Media
The experimental drug, which is still in research studies, is being advertised by social media influencers for its alleged fat-burning effects. Followers are urged to contact these accounts directly for source information, while also obtaining discount codes.
Thriving Commerce on Messaging Platforms
Separately, a flourishing market exists on messaging services, where communities with numerous of members share “before and after” images, injection guides and claims of next-day UK delivery. Vendors promote the substance there before redirecting buyers to WhatsApp for purchases.
Understanding Retatrutide
This medication is an investigational injectable created by American pharmaceutical company Eli Lilly. The drug affects three gut hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Early trials indicate it could help individuals lose up to 25% of their total weight. Nicknamed the “triple G”, the drug is being promoted online as the successor to Ozempic.
Medical Professionals Express Concerns
Nevertheless, doctors and chemists have cautions that the sale of what is still an unlicensed drug in the United Kingdom is worrisome and could lead to users injecting substances of unknown origin.
Several professionals said the popularity for retatrutide could be linked to the rising price of approved weight loss treatments such as Mounjaro.
Regulatory Status and Enforcement
Marketing the unapproved drug on social media or Telegram is prohibited in the United Kingdom, as it is an unapproved drug that cannot be marketed or supplied for personal consumption under the British medical regulations.
Several influencers attempt to circumvent the regulations by referring to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted drug, but promotion and distribution can still breach pharmaceutical, advertising, and customer regulations, potentially leading to fines, prosecution or imprisonment.
Service Reaction and Content Elimination
Based on TikTok, the platform has taken down problematic content and prohibited related keywords and search suggestions. The organization stated it was committed to maintaining the platform safe and allocating resources in strengthening compliance measures.
Online Marketplace Operations
Investigations also found groups with up to 9,000 members selling the experimental drug using Telegram's built-in search feature, which operates like a online catalog. Entering “retatrutide” instantly displays channels with thousands of users, filled with photos of weight loss, positive reviews and step-by-step instructions for preparing or administering at home.
Within minutes of joining one group, a seller posted WhatsApp details, where the majority of transactions take place. The vendor provided an instruction manual and guaranteed delivery within two days. When asked whether the product was genuine, one vendor said: “You can’t be sure.” Another shared a photo of a alleged laboratory certificate. Not one inquired about body mass, medical conditions or past usage.
Item Information and Costs
Within these communities, messages show dark colored parcels with Royal Mail labels, claiming to contain fresh supplies. One message stated: “It took eight of us to load them this morning.”
Buyers can choose between powder vials, prepared at home with sterile water, or ready-to-use pens typically priced at 160 pounds for 20mg. When asked how long a injector should last, vendors give contradictory responses varying between a few weeks to “depends on your body”.
Platform Moderation and Safety Actions
A spokesperson for the messaging service stated it regularly monitored harmful content on its platform including material that encouraged the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.
Medical Professional Warnings
“People are administering materials they cannot confirm. Even if the science behind this drug is valid, these digital versions may not include what they claim,” stated Jason Murphy, the director of pharmaceutical services at Chemist4U.
A medical professional of an online medical service linked the surge in demand to recent price rises for authorized slimming medications such as Mounjaro. “With costs increasing, patients are turning to online platforms. But fake injections are extremely risky. You cannot know what’s inside or whether the environment they were made in was clean,” she said.
Her staff has already seen individuals harmed by personal administration from unverified sources. “We understand the disappointment, but purchasing from messaging apps or communication platforms is taking chances with your well-being,” said the doctor. “These materials could be impure or incorrectly dosed.”
Producer Position
A spokesperson from the pharmaceutical company said the substance was in phase 3 clinical trials and had not been evaluated or authorized by any government authority globally. “Therefore at this time no one can market [it] for personal consumption,” they said, adding that any item “falsely representing itself as a Lilly experimental product not yet approved … may expose patients to possibly significant health risks”.
